Breaking News, Collaborations & Alliances

mAbxience Bolsters Biosimilar and CDMO Manufacturing Capacity

Utilizing ABEC Custom Single Run technology to increase flexibility and productivity.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, said that mAbxience will equip their state-of-the-art cGMP facility in León, Spain with an ABEC 4,000L Custom Single Run (CSR) Bioreactor. The system will be commissioned mid-2021 and will increase biosimilar and CDMO manufacturing capacity at the León site.   The 4,000L volume and performance comparable to stainless steel systems will enable mAbxience to improve flexibility, productivity and effici...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters